POMT1 is essential for protein O-mannosylation in mammals

Methods in Enzymology

Volumn 479, Issue C, 2010, Pages 323-342

  Lommel, Mark ^a   Willer, Tobias ^b   Cruces, Jesús ^c   Strahl, Sabine ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; LAMININ; MANNOSYLTRANSFERASE; PROTEIN O MANNOSYLTRANSFERASE 1; PROTEIN O MANNOSYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ADOLESCENT; BINDING AFFINITY; BOOK; EMBRYO; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIGAND BINDING; MOUSE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EUKARYOTA; FUNGI; MAMMALIA; MUS;

EID: 77956204133     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)79018-2     Document Type: Chapter

References (43)

1. Ackroyd M.R., Skordis L., Kaluarachchi M., Godwin J., Prior S., Fidanboylu M., Piercy R.J., Muntoni F., Brown S.C. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009, 132:439-451.
2. Barresi R., Campbell K.P. Dystroglycan: From biosynthesis to pathogenesis of human disease. J. Cell Sci. 2006, 119:199-207.
3. Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., Celli J., van Beusekom E., van der Zwaag B., Kayserili H., Merlini L., Chitayat D., Dobyns W.B., Cormand B., Lehesjoki A.E., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 2002, 71:1033-1043.
4. Blake D.J., Martin-Rendon E. Intermediate filaments and the function of the dystrophin-protein complex. Trends Cardiovasc. Med. 2002, 12:224-228.
5. Breloy I., Schwientek T., Gries B., Razawi H., Macht M., Albers C., Hanisch F.G. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain. J. Biol. Chem. 2008, 283:18832-18840.
6. Brockington M., Blake D.J., Prandini P., Brown S.C., Torelli S., Benson M.A., Ponting C.P., Estournet B., Romero N.B., Mercuri E., Voit T., Sewry C.A., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 2001, 69:1198-1209.
7. Chiba A., Matsumura K., Yamada H., Inazu T., Shimizu T., Kusunoki S., Kanazawa I., Kobata A., Endo T. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 1997, 272:2156-2162.
8. Deconinck N., Dan B. Pathophysiology of duchenne muscular dystrophy: Current hypotheses. Pediatr. Neurol. 2007, 36:1-7.
9. Endo T., Manya H. O-Mannosylation in mammalian cells. Methods Mol. Biol. 2006, 347:43-56.
10. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1983, 132:6-13.
11. Grewal P.K., Holzfeind P.J., Bittner R.E., Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 2001, 28:151-154.
12. Han R., Kanagawa M., Yoshida-Moriguchi T., Rader E.P., Ng R.A., Michele D.E., Muirhead D.E., Kunz S., Moore S.A., Iannaccone S.T., Miyake K., McNeil P.L., et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc. Natl. Acad. Sci. USA 2009, 106:12573-12579.
13. Hewitt J.E. Abnormal glycosylation of dystroglycan in human genetic disease. Biochim. Biophys. Acta 2009, 1792:853-861.
14. Jurado L.A., Coloma A., Cruces J. Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1. Genomics 1999, 58:171-180.
15. Kanagawa M., Nishimoto A., Chiyonobu T., Takeda S., Miyagoe-Suzuki Y., Wang F., Fujikake N., Taniguchi M., Lu Z., Tachikawa M., Nagai Y., Tashiro F., et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum. Mol. Genet. 2009, 18:621-631.
16. Kobayashi K., Sasaki J., Kondo-Iida E., Fukuda Y., Kinoshita M., Sunada Y., Nakamura Y., Toda T. Structural organization, complete genomic sequences and mutational analyses of the Fukuyama-type congenital muscular dystrophy gene, fukutin. FEBS Lett. 2001, 489:192-196.
17. Kurahashi H., Taniguchi M., Meno C., Taniguchi Y., Takeda S., Horie M., Otani H., Toda T. Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol. Dis. 2005, 19:208-217.
18. Lehle L., Strahl S., Tanner W. Protein glycosylation, conserved from yeast to man: A model organism helps elucidate congenital human diseases. Angew. Chem. Int. Ed. Engl. 2006, 45:6802-6818.
19. Liu J., Ball S.L., Yang Y., Mei P., Zhang L., Shi H., Kaminski H.J., Lemmon V.P., Hu H. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 2006, 123:228-240.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
21. Lommel M., Strahl S. Protein O-mannosylation: Conserved from bacteria to humans. Glycobiology 2009, 19:816-828.
22. Lommel M., Willer T., Strahl S. POMT2, a key enzyme in Walker-Warburg syndrome: Somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo. Glycobiology 2008, 18:615-625.
23. Lommel M., Cirak S., Willer T., Hermann R., Uyanik G., van Bokhoven H., Korner C., Voit T., Baric I., Hehr U., Strahl S. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies. Neurology 2010, 74:157-164.
24. Longman C., Brockington M., Torelli S., Jimenez-Mallebrera C., Kennedy C., Khalil N., Feng L., Saran R.K., Voit T., Merlini L., Sewry C.A., Brown S.C., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 2003, 12:2853-2861.
25. Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y., Margolis R.U., Endo T. Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl. Acad. Sci. USA 2004, 101:500-505.
26. Mercuri E., Messina S., Bruno C., Mora M., Pegoraro E., Comi G.P., D'Amico A., Aiello C., Biancheri R., Berardinelli A., Boffi P., Cassandrini D., et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population study. Neurology 2009, 72:1802-1809.
27. Michele D.E., Campbell K.P. Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J. Biol. Chem. 2003, 278:15457-15460.
28. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., Straub V., Mathews K.D., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002, 418:417-422.
29. Miyagoe-Suzuki Y., Masubuchi N., Miyamoto K., Wada M.R., Yuasa S., Saito F., Matsumura K., Kanesaki H., Kudo A., Manya H., Endo T., Takeda S. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech. Dev. 2009, 126:107-116.
30. Muntoni F., Brockington M., Torelli S., Brown S.C. Defective glycosylation in congenital muscular dystrophies. Curr. Opin. Neurol. 2004, 17:205-209.
31. Nagy A., Gertsenstein M., Vintersten K., Behringer R. Manipulating the Mouse Embryo. 2003, Cold Spring Habor aboratory Press, Cold Spring Habor, New York.
32. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 1993, 90:3710-3714.
33. Prados B., Pena A., Cotarelo R.P., Valero M.C., Cruces J. Expression of the murine Pomt1 gene in both the developing brain and adult muscle tissues and its relationship with clinical aspects of Walker-Warburg syndrome. Am. J. Pathol. 2007, 170:1659-1668.
34. Salamat M., Miosge N., Herken R. Development of Reichert's membrane in the early mouse embryo. Anat. Embryol. (Berl). 1995, 192:275-281.
35. Sasaki T., Yamada H., Matsumura K., Shimizu T., Kobata A., Endo T. Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim. Biophys. Acta 1998, 1425:599-606.
36. Sporle R., Gunther T., Struwe M., Schughart K. Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos. Development 1996, 122:79-86.
37. Tybulewicz V.L., Crawford C.E., Jackson P.K., Bronson R.T., Mulligan R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991, 65:1153-1163.
38. van Reeuwijk J., Janssen M., van den Elzen C., Beltran-Valero de Bernabe D., Sabatelli P., Merlini L., Boon M., Scheffer H., Brockington M., Muntoni F., Huynen M.A., Verrips A., et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J. Med. Genet. 2005, 42:907-912.
39. Willer T., Amselgruber W., Deutzmann R., Strahl S. Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology 2002, 12:771-783.
40. Willer T., Valero M.C., Tanner W., Cruces J., Strahl S. O-Mannosyl glycans: From yeast to novel associations with human disease. Curr. Opin. Struct. Biol. 2003, 13:621-630.
41. Willer T., Prados B., Falcon-Perez J.M., Renner-Muller I., Przemeck G.K., Lommel M., Coloma A., Valero M.C., de Angelis M.H., Tanner W., Wolf E., Strahl S., et al. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc. Natl. Acad. Sci. USA 2004, 101:14126-14131.
42. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee J.C., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K.P. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 1997, 6:831-841.
43. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., Herrmann R., Straub V., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell. 2001, 1:717-724.